Fdc share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹431.60(0.14%)April 22, 2025 15:28:01 PM IST
- NSE
- BSE
- Vol : 153.63K (NSE + BSE)Last 20 day avg : 156.88 K
Fdc is trading 0.14% upper at Rs 431.60 as compared to its last closing price. Fdc has been trading in the price range of 440.95 & 425.95. Fdc has given -13.79% in this year & 5.85% in the last 5 days. Fdc has TTM P/E ratio 29.77 as compared to the sector P/E of 28.79.The company posted a net profit of 37.04 Crores in its last quarter.Listed peers of Fdc include Marksans Pharma (-%), Procter & Gamble Health (-1.44%), Fdc (0.14%).The Mutual Fund holding in Fdc was at 6.18% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Fdc was at 2.56% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Key Metrics
Updated on Apr 23, 2025, 02:54 AM UTC
- Dividend YieldHigher than industry1.16Annual dividends as a percentage of the stock price.
- P/BHigher than historical values3.34The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values25.67Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation16.15The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- BetaLow volatility0.63Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Fdc News
Fdc Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 1.30% from Rs 464.11 crore to Rs 458.17 crore, year-on-year
The company's profit declined by 53.25% year-on-year during the December quarter, dropping from Rs 79.23 crore to Rs 37.04 crore- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
Fdc Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 437.18
- R2
- 480.07
- R3
- 519.18
Pivot398.07
- S1
- 355.18
- S2
- 316.07
- S3
- 273.18
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Fdc Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Marksans Pharma | Moderately Bearish | 214.25 | - | 9,699.88 | 29.78 | 4.7 | 0.28 | 9.20 |
| Procter & Gamble Health | Bearish | 5,161.05 | -1.44 | 8,552.47 | 39.81 | 16.11 | 2.68 | 1.28 |
| Fdc | Neutral | 431.60 | 0.14 | 7,043.25 | 23.43 | 3.34 | - | 0.60 |
| Aarti Pharmalabs | Bullish | 709.60 | -0.21 | 6,432.31 | 29.79 | 3.68 | - | 0.95 |
| Shilpa Medicare | Neutral | 676.45 | 2.70 | 6,695.80 | 204.39 | 3.16 | - | 31.04 |
Fdc Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Fdc is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 69.66%
- FIIs are invested in this company
- FIIs holding has decreased by 0.11 percentage points from previous quarter
- Mutual Funds holding has increased by 0.31 percentage points from previous quarter
Mutual Fund Ownership
View allFdc Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-12 | Quarterly Results & Others |
| 2024-11-06 | Quarterly Results & Others |
| 2024-08-07 | Quarterly Results |
| 2024-05-29 | Audited Results |
| 2024-02-07 | Quarterly Results |
About the company Fdc
- IndustryBiotechnology & Drugs
- ISININE258B01022
- BSE Code531599
- NSE CodeFDC
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Fdc Share Price FAQs
Fdc is trading at 431.60 as on Tue Apr 22 2025 09:58:01. This is 0.14% upper as compared to its previous closing price of 431.00.
The market capitalization of Fdc is 7043.25 Cr as on Tue Apr 22 2025 09:58:01.
The 52 wk high for Fdc is 659.00 whereas the 52 wk low is 358.95
Fdc can be analyzed on the following key metrics -
- TTM P/E: 29.77
- Sector P/E: 28.79
- Dividend Yield: 1.16%
- D/E ratio: -
Fdc reported a net profit of 305.22 Cr in 2024.
The Mutual Fund Shareholding was 6.18% at the end of 31 Mar 2025.
Quick Links